New Drug May Fight a Deadly Bone Marrow Disorder
TUESDAY, Aug. 5, 2025 (HealthDay News) — A recently approved leukemia pill also might help some patients diagnosed with a deadly bone marrow disorder, a new pilot study says. About 3 in 5 patients with myelodysplastic syndrome (MDS) responded to treatment with olutasidenib (Rezlidhia), which the U.S. Food and DrugContinue Reading










